Illumina Taps Dx Veteran Mike Sullivan as Chief Commercial Officer, Adds Top Lawyer
Sullivan brings experience from Caris, Roche, Ortho Clinical and Abbott; Julie Coletti joins as chief legal officer in August.
Illumina has named Mike Sullivan as chief commercial officer, effective July 20. The company also appointed Julie Coletti as chief legal officer.
Sullivan comes from Caris Life Sciences, where he served as chief commercial officer overseeing global commercial operations across oncology diagnostics and precision medicine. Before Caris, he held senior commercial leadership roles at Roche Diagnostics, Ortho Clinical Diagnostics, IDEXX Laboratories and Abbott Diagnostics.
“[Sullivan] brings deep commercial expertise, a customer-first mindset, and significant experience scaling global organizations,” Illumina CEO Jacob Thaysen said in a statement.
He also brings decades of experience in diagnostics, a major driver in the growth of clinical sequencing, now Illumina’s largest end market.
Coletti’s appointment is effective Aug. 3. She will lead the company’s global legal, regulatory, and government affairs teams as well as serve as corporate secretary to Illumina’s board. She joins from Align Technology, where she was chief legal and regulatory officer. Before that, she held senior legal leadership roles at Danaher and Bayer HealthCare. She also serves as a director for Fortis Life Sciences.